Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teva Pharmaceutical

15.99
-0.0500-0.31%
Volume:8.17M
Turnover:130.38M
Market Cap:18.34B
PE:-13.99
High:16.10
Open:16.00
Low:15.82
Close:16.04
Loading ...
Feb 09, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 06, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 27, 2021

Major Issues Report

8-K - Current report
Oct 27, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 27, 2021

Major Issues Report

8-K - Current report
Jul 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report
Jul 21, 2021

Major Issues Report

8-K - Current report
Jul 06, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Major Issues Report

8-K - Current report
Apr 28, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 28, 2021

Major Issues Report

8-K - Current report
Apr 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 10, 2021

Major Issues Report

8-K - Current report